Cargando…

Response to Letter to the Editor: “Hypertension and Type 2 Diabetes Are Associated With Decreased Inhibition of Dipeptidyl Peptidase-4 by Sitagliptin”

Detalles Bibliográficos
Autores principales: Wilson, Jessica R, Shuey, Megan M, Brown, Nancy J, Devin, Jessica K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049288/
https://www.ncbi.nlm.nih.gov/pubmed/32133430
http://dx.doi.org/10.1210/jendso/bvaa006
_version_ 1783502410695573504
author Wilson, Jessica R
Shuey, Megan M
Brown, Nancy J
Devin, Jessica K
author_facet Wilson, Jessica R
Shuey, Megan M
Brown, Nancy J
Devin, Jessica K
author_sort Wilson, Jessica R
collection PubMed
description
format Online
Article
Text
id pubmed-7049288
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-70492882020-03-04 Response to Letter to the Editor: “Hypertension and Type 2 Diabetes Are Associated With Decreased Inhibition of Dipeptidyl Peptidase-4 by Sitagliptin” Wilson, Jessica R Shuey, Megan M Brown, Nancy J Devin, Jessica K J Endocr Soc Letter to the Editor-Response Oxford University Press 2020-02-29 /pmc/articles/PMC7049288/ /pubmed/32133430 http://dx.doi.org/10.1210/jendso/bvaa006 Text en © Endocrine Society 2020. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letter to the Editor-Response
Wilson, Jessica R
Shuey, Megan M
Brown, Nancy J
Devin, Jessica K
Response to Letter to the Editor: “Hypertension and Type 2 Diabetes Are Associated With Decreased Inhibition of Dipeptidyl Peptidase-4 by Sitagliptin”
title Response to Letter to the Editor: “Hypertension and Type 2 Diabetes Are Associated With Decreased Inhibition of Dipeptidyl Peptidase-4 by Sitagliptin”
title_full Response to Letter to the Editor: “Hypertension and Type 2 Diabetes Are Associated With Decreased Inhibition of Dipeptidyl Peptidase-4 by Sitagliptin”
title_fullStr Response to Letter to the Editor: “Hypertension and Type 2 Diabetes Are Associated With Decreased Inhibition of Dipeptidyl Peptidase-4 by Sitagliptin”
title_full_unstemmed Response to Letter to the Editor: “Hypertension and Type 2 Diabetes Are Associated With Decreased Inhibition of Dipeptidyl Peptidase-4 by Sitagliptin”
title_short Response to Letter to the Editor: “Hypertension and Type 2 Diabetes Are Associated With Decreased Inhibition of Dipeptidyl Peptidase-4 by Sitagliptin”
title_sort response to letter to the editor: “hypertension and type 2 diabetes are associated with decreased inhibition of dipeptidyl peptidase-4 by sitagliptin”
topic Letter to the Editor-Response
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049288/
https://www.ncbi.nlm.nih.gov/pubmed/32133430
http://dx.doi.org/10.1210/jendso/bvaa006
work_keys_str_mv AT wilsonjessicar responsetolettertotheeditorhypertensionandtype2diabetesareassociatedwithdecreasedinhibitionofdipeptidylpeptidase4bysitagliptin
AT shueymeganm responsetolettertotheeditorhypertensionandtype2diabetesareassociatedwithdecreasedinhibitionofdipeptidylpeptidase4bysitagliptin
AT brownnancyj responsetolettertotheeditorhypertensionandtype2diabetesareassociatedwithdecreasedinhibitionofdipeptidylpeptidase4bysitagliptin
AT devinjessicak responsetolettertotheeditorhypertensionandtype2diabetesareassociatedwithdecreasedinhibitionofdipeptidylpeptidase4bysitagliptin